PLK4 and skin cancer: Thus, there is a possibility of an interaction between PLK4 and Hippo/YAP pathway components, or PLK4-mediated constant centrosome amplification works synergistically with the dysregulation of Hippo/YAP signaling allowing oncogenic activity of YAP in skin cancer.